Avalo Therapeutics (AVTX) Asset Utilization Ratio (2017 - 2025)
Avalo Therapeutics' Asset Utilization Ratio came in at 0.00 for Q4 2025, up 17.0% from 0.00 a year earlier and up 18.1% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Asset Utilization Ratio (2017 - 2025) Analysis & Trends
Going back to Q2 2017, Avalo Therapeutics' Asset Utilization Ratio data covers 33 quarters.
- Asset Utilization Ratio has declined in each of the last three years.
- Going back by year, Asset Utilization Ratio was 0.01 in FY2024 (-92.7%), 0.07 in FY2023 (-77.7%), 0.32 in FY2022 (+265.0%) and 0.09 in FY2021 (-48.1%).
- The Q4 2025 figure represents the highest quarterly Asset Utilization Ratio since Q3 2024.
- Year-over-year, Asset Utilization Ratio increased in 1 of the last six quarters, with an average decline of 69.9%.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q4 2022 (growth of 739.9%), and the weakest in Q2 2024 (a decline of 98.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 0.47 |
| 10 | Avalo Therapeutics | 679.32 Mn | 679.32 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.08 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.56 |
| Mar 31, 2023 | 0.50 |
| Dec 31, 2022 | 0.52 |
| Sep 30, 2022 | 0.51 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.09 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.08 |
| Jun 30, 2021 | 0.10 |
| Mar 31, 2021 | 0.08 |
| Dec 31, 2020 | 0.13 |
| Sep 30, 2020 | 0.09 |
API Access
Avalo Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();